Company Name: Vermillion, Inc.
Vermillion, Inc. develops diagnostics used to detect and improve the treatment of gynecologic disease in women. The company’s OVA1® is a blood test that is designed to aid the physician in determining whether or not an ovarian mass is malignant before surgery is performed.
Ticker Symbol: VRML (NASDAQ)
Company Website: www.vermillion.com
Social Media: Vermillion LinkedIn Page
Headquarters: Austin, TX